Innovative approaches in UNMET clinical needs for maximum health care impact - Translational aspects
22 SEPTEMBER
14:00 - 15:30
| |
go to QR-CODE |
| ROOM 8 | |||
| HEALTH | |||
| NANOMEDICINE |
|||
| TT.III - Technical Multi-Track with Parallel SYMPOSIA | |||
| Innovative approaches in UNMET clinical needs for maximum health care impact - Translational aspects |
|||
| Co-organized with Don Gnocchi Foundation, University of Modena and Reggio Emilia, University of Catanzaro and Sapienza University of Rome Chairs: Marzia BEDONI, Don Gnocchi Foundation & Giovanni TOSI - CV, University of Modena and Reggio Emilia |
|||
|
In this day, different actors (academia, industry, regulatory) will discuss and describe the development of innovative and enabling technologies for facing unmet clinical needs, varying from diagnosis to therapeutic aims. In line with Horizon Europe pipelines, pathological focuses will be devoted on cancer, brain related diseases, cardiovascular pathologies. A comprehensive overview of the recent and established innovation in health technologies will be highlighted with a special focus on several aspects strongly impacting on the success of innovation approaches and its application into clinical setting and shown by different sides of view, from design, to materials, characterization, production and scale up, ending to successful stories of yet approved and on market technologies. |
|||
| The symposium is part of the workshop WS.II | |||
| TT.III.D.1 WS.II.3.1 |
Furio GRAMATICA - CV Don Gnocchi Foundation Crosstech innovation in Horizon Europe |
 |
 |
| TT.III.D.2 WS.II.3.2 |
Dora MEHN - CV European Commission, Directorate General Joint Research Centre, Directorate F – Health, Consumers and Reference Materials, Consumer Products Safety (EU) Advanced methods for sizing nanomedicine materials |
 |
 |
| TT.III.D.3 WS.II.3.3 |
Fanny CAPUTO - CV Sintef, Norway Measuring physical properties of liposomes and of lipid-based nanoparticles for RNA delivery: from method development to standardization |
 |
 |
| TT.III.D.4 WS.II.3.4 |
Michele DE LUCA - CV University of Modena and Reggio Emilia & Holostem Combined cell and gene therapy for epidermolysis bullosa |
|
 |
| TT.III.D.5 WS.II.3.5 |
Sabrina PRICI University of Trieste & COST Action Nano2Clinic Cancer nanomedicine from the bench to the bedside |
|
 |
| TT.III.D.6 WS.II.3.6 |
Maria DE LA FUENTE - CV Oncomet, Spain DIVERSA, Delivery Innovation for VERsatile Solutions in Advanced Therapeutics |
|
 |
 Back to Thematic Workshops & Symposia |
Back to Plan 22 September  |
|
